{"schema_version":"alpha-profile-public-v1","slug":"g-bradley-cole","canonical_url":"https://registry.alpha.ac/people/g-bradley-cole","as_of":"2026-09-21T23:53:15.659635+00:00","published_at":"2026-09-02T02:37:24.213848+00:00","last_reviewed_at":"2026-05-16T00:40:55.418+00:00","identity":{"display_name":"G. Bradley Cole","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Kiniksa Pharmaceuticals International, plc","company_slug":"kiniksa-pharmaceuticals-international-plc","exchange":"NASDAQ","ticker":"KNSA","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2020-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","effective_date":"2026-04-16","last_checked_at":"2026-04-24T23:31:01.873+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=g-bradley-cole","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=g-bradley-cole&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["CFO of Genomic Life since February 2022. Previously served as CFO of Genomic Health and COO roles at multiple life sciences companies. Extensive experience in finance and operations across genomics and precision oncology sectors."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Kiniksa Pharmaceuticals International, plc","organizationId":"kiniksa-pharmaceuticals-international-plc","title":"Director","period":"2020-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Kiniksa Pharmaceuticals International, plc","company_slug":"kiniksa-pharmaceuticals-international-plc","exchange":"NASDAQ","ticker":"KNSA","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2020-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","effective_date":"2026-04-16","last_checked_at":"2026-04-24T23:31:01.873+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for G. Bradley Cole as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:40:55.581032+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KNSA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","published_at":"2026-04-16T00:00:00+00:00","last_checked_at":"2026-05-16T00:40:55.478938+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"G. Bradley Cole currently serves as Director at Kiniksa Pharmaceuticals International, plc.","claim_state":"verified","valid_from":"2026-04-16","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:40:55.546085+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KNSA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","published_at":"2026-04-16T00:00:00+00:00","last_checked_at":"2026-05-16T00:40:55.478938+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit"],"claim_text":"G. Bradley Cole serves on Audit.","claim_state":"verified","valid_from":"2026-04-16","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:40:55.564009+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KNSA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","published_at":"2026-04-16T00:00:00+00:00","last_checked_at":"2026-05-16T00:40:55.478938+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Genomic Life, Inc.","claim_text":"G. Bradley Cole is linked to Genomic Life, Inc. as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:40:55.718228+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KNSA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","published_at":"2026-04-16T00:00:00+00:00","last_checked_at":"2026-05-16T00:40:55.478938+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Financial Officer","claim_text":"G. Bradley Cole is also listed as Chief Financial Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:40:55.691713+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KNSA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","published_at":"2026-04-16T00:00:00+00:00","last_checked_at":"2026-05-16T00:40:55.478938+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for G. Bradley Cole as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:40:55.614901+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KNSA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","published_at":"2026-04-16T00:00:00+00:00","last_checked_at":"2026-05-16T00:40:55.478938+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for G. Bradley Cole as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:40:55.598807+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KNSA DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","published_at":"2026-04-16T00:00:00+00:00","last_checked_at":"2026-05-16T00:40:55.478938+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:g-bradley-cole","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2020-01-01 · current","organization":"Kiniksa Pharmaceuticals International, plc","organization_id":"kiniksa-pharmaceuticals-international-plc"},"claim_text":"Director at Kiniksa Pharmaceuticals International, plc (2020-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/g-bradley-cole#profile","url":"https://registry.alpha.ac/people/g-bradley-cole","dateModified":"2026-05-16T00:40:55.418+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/g-bradley-cole#person","name":"G. Bradley Cole","url":"https://registry.alpha.ac/people/g-bradley-cole","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Kiniksa Pharmaceuticals International, plc","tickerSymbol":"NASDAQ: KNSA"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2020-01-01","memberOf":{"@type":"Organization","name":"Kiniksa Pharmaceuticals International, plc","url":"https://registry.alpha.ac/companies/kiniksa-pharmaceuticals-international-plc","tickerSymbol":"NASDAQ: KNSA"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm","name":"KNSA DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/g-bradley-cole"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-16T00:40:55.418+00:00","observed_at":"2026-09-21T23:53:15.659635+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"g-bradley-cole","canonical_url":"https://registry.alpha.ac/people/g-bradley-cole"},"publication":{"published_at":"2026-09-02T02:37:24.213848+00:00","last_reviewed_at":"2026-05-16T00:40:55.418+00:00","as_of":"2026-09-21T23:53:15.659635+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/g-bradley-cole","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/g-bradley-cole","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/g-bradley-cole.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}